How LSD1 inhibition would affect the non-canonical functions of GFI1 in DNA repair or in regulating the activity of p53 has not yet been addressed, but would provide important information to evaluate the impact that these drug candidates may have on myeloid leukemia or other malignancies. This evidence concerns the gene TP53 and myeloid leukemia.